drug · oligonucleotide
autogene cevumeran
Phase 2updated 3mo agoby Genentech Inc🔗 ChEMBL
Phase 2community read0 votes
Oligonucleotide drug with a maximum clinical stage of Phase 2 (across all indications), with 5 investigational indications.
indications
indications
Colorectal Cancer
all catalysts(0)
nothing on the calendar yet
Trials studying autogene cevumeran
- phase2A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
- phase2A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
- phase2A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma.
- phase1A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3m ago
Found something off?
comments(0)
5-min edit window · permanent after that